Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

1,363 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Completed

A Phase 1b Trial in Patients With Renal Cell Cancer

NCT01258348

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenville, South Carolina, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Norfolk, Virginia, United States
View Trial Details
Completed

A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers

NCT01743469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Gastric Carcinoma, +38 more
Locations
  • Antwerp University Hospital, Wilrijkstraat 10 Edegem, Belgium
  • Ghent University Hospital, 1K12 IE, De Pintelaan 185 Ghent, Belgium
  • Leuven cancer institute (LKI), Herestraat Leuven, Belgium
  • Juravinski Cancer Centre, 699 Concession St Hamilton, Ontario, Canada
View all 24 locations
View Trial Details
Completed

Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery

NCT01688973

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 214 locations
View Trial Details
Completed

A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies

NCT00923520

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +43 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
  • Hershey Medical Center Hershey, Pennsylvania, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer

NCT00087022

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Anchorage, Alaska, United States
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Helen F. Graham Cancer Center at Christiana Hospital Newark, Delaware, United States
View all 56 locations
View Trial Details
Completed

Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma

NCT01762150

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen university cancer center Guangzhou, Guangdong, China
  • Shenyang general hospital of Shenyang military command Shenyang, Liaoning, China
  • Xijing Hospital Xi’an, Shanxi, China
View Trial Details

Related conditions